These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37999735)

  • 1. Genomic alterations and diagnosis of renal cancer.
    Zhang X; Bolck HA; Rupp NJ; Moch H
    Virchows Arch; 2024 Feb; 484(2):323-337. PubMed ID: 37999735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification.
    Rizzo M; Caliò A; Brunelli M; Pezzicoli G; Ganini C; Martignoni G; Camillo P
    Cancer Treat Rev; 2023 May; 116():102558. PubMed ID: 37060647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights in the new WHO classification of adult renal tumors.
    Hes O; Michalová K; Pivovarčíková K
    Cesk Patol; 2022; 67(4):187-191. PubMed ID: 36513503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The New WHO Category of "Molecularly Defined Renal Carcinomas": Clinical and Diagnostic Features and Management Implications.
    Kanakaraj J; Chang J; Hampton LJ; Smith SC
    Urol Oncol; 2024 Jul; 42(7):211-219. PubMed ID: 38519377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer.
    Williamson SR; Gill AJ; Argani P; Chen YB; Egevad L; Kristiansen G; Grignon DJ; Hes O
    Am J Surg Pathol; 2020 Jul; 44(7):e47-e65. PubMed ID: 32251007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of uncommon renal epithelial neoplasms: performances of fluorescence in situ hybridization.
    Beaumont M; Dugay F; Kammerer-Jacquet SF; Jaillard S; Cabillic F; Mathieu R; Verhoest G; Bensalah K; Rioux-Leclercq N; Belaud-Rotureau MA;
    Hum Pathol; 2019 Oct; 92():81-90. PubMed ID: 31437522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocation carcinomas of the kidney.
    Argani P
    Genes Chromosomes Cancer; 2022 May; 61(5):219-227. PubMed ID: 34704642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Selected High-grade Renal Cell Carcinomas of the Kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas.
    Chen YB
    Adv Anat Pathol; 2024 Mar; 31(2):118-125. PubMed ID: 38145398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The WHO 2022 Classification of Renal Neoplasms (5th Edition): Salient Updates.
    Goswami PR; Singh G; Patel T; Dave R
    Cureus; 2024 Apr; 16(4):e58470. PubMed ID: 38765391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally invasive cytologic evaluation leading to the diagnosis of TFE3-rearranged renal cell carcinoma: A case report.
    Gama A; Sukhanova M; Choy B
    Diagn Cytopathol; 2022 Dec; 50(12):E382-E385. PubMed ID: 35975764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's new in the WHO 2022 classification of kidney tumours?
    Alaghehbandan R; Siadat F; Trpkov K
    Pathologica; 2022 Feb; 115(1):8-22. PubMed ID: 36645398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Entities in Renal Neoplasia.
    Mehra R; Smith SC; Divatia M; Amin MB
    Surg Pathol Clin; 2015 Dec; 8(4):623-56. PubMed ID: 26612218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
    Moch H; Amin MB; Berney DM; Compérat EM; Gill AJ; Hartmann A; Menon S; Raspollini MR; Rubin MA; Srigley JR; Hoon Tan P; Tickoo SK; Tsuzuki T; Turajlic S; Cree I; Netto GJ
    Eur Urol; 2022 Nov; 82(5):458-468. PubMed ID: 35853783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup.
    Liu YJ; Houldsworth J; Emmadi R; Dyer L; Wolff DJ
    Cancer Genet; 2020 Jun; 244():40-54. PubMed ID: 32434132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma.
    Wang XM; Zhang Y; Mannan R; Skala SL; Rangaswamy R; Chinnaiyan A; Su F; Cao X; Zelenka-Wang S; McMurry L; Xiao H; Spratt DE; Sangoi AR; Shao L; Betz BL; Brown N; Tickoo SK; McKenney JK; Argani P; Gupta S; Reuter VE; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Mod Pathol; 2021 Aug; 34(8):1596-1607. PubMed ID: 33854184
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Wangsiricharoen S; Zhong M; Ranganathan S; Matoso A; Argani P
    Int J Surg Pathol; 2021 Oct; 29(7):808-814. PubMed ID: 33729862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of clinicopathological features of rearranged renal cell carcinoma and TFE3, TFEB, and ALK staining performance in renal entities.
    Liu Y; Li X; Fan Y; Xu H; Gu Y; Dong L; Zhou L; Yang X; Wang C
    Heliyon; 2023 Apr; 9(4):e15159. PubMed ID: 37089387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing.
    Cajaiba MM; Dyer LM; Geller JI; Jennings LJ; George D; Kirschmann D; Rohan SM; Cost NG; Khanna G; Mullen EA; Dome JS; Fernandez CV; Perlman EJ
    Cancer; 2018 Aug; 124(16):3381-3389. PubMed ID: 29905933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of ALK-rearranged renal cell carcinomas with a focus on clinical and pathobiological aspects.
    Kuroda N; Sugawara E; Kusano H; Yuba Y; Yorita K; Takeuchi K
    Pol J Pathol; 2018; 69(2):109-113. PubMed ID: 30351856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from 801 clinical TFE3/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF family aberrations.
    Wang XM; Shao L; Xiao H; Myers JL; Pantanowitz L; Skala SL; Udager AM; Vaishampayan U; Mannan R; Dhanasekaran SM; Chinnaiyan AM; Betz BL; Brown N; Mehra R
    Am J Clin Pathol; 2023 Dec; 160(6):549-554. PubMed ID: 37499055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.